Gapping down
In reaction to disappointing earnings/guidance: DYSL -27% (thinly traded), KMX -8.8%, KNX -7.4% ( lowers Q4 EPS guidance below consensus, also downgraded to Neutral from Buy at Citigroup), AKS -2% (provides Q4 EPS guidance including charges; sees Q4 shipments of 1.6 mln tons, down 14% QoQ)
In reaction to disappointing earnings/guidance: DYSL -27% (thinly traded), KMX -8.8%, KNX -7.4% ( lowers Q4 EPS guidance below consensus, also downgraded to Neutral from Buy at Citigroup), AKS -2% (provides Q4 EPS guidance including charges; sees Q4 shipments of 1.6 mln tons, down 14% QoQ)
M&A related: WFC -0.3% (Wells Fargo to sell its crop insurance business to Zurich Insurance).
Select telecom names showing early weakness: TSU -5.3%, VIV -3.6%, TEF -2.9%, TMUS -1.3%.
Other news: OSIR -12.8% (independent registered public accounting firm BDO USA resigns), QURE -8.6% (appoints Dan Soland as new CEO), ICPT -6.6% (FDA extends PDUFA date for Obeticholic acid for the treatment of PBC to May 29, 2016), VTAE -6.3% (announces top-line clinical efficacy results from the remaining monotherapy arm of Boehringer Ingelheim's Phase 2 trial of BI187004 in type 2 diabetes), VNR -5.7% (lowers monthly distribution to $0.03/unit from $0.1175/unit), ARIA -3.6% (confirms the appointment of Paris Panayiotopoulos as President and Chief Executive Officer, effective Jan. 1 2016), SWFT -3.3% (following KNX guidance), SCTY -2.9% (Jim Chanos reiterating cautious stance on SCTY- CNBC), YNDX -2.4% (Russia names weaker after Ukraine defaulted on $3 bln bond to Russia), VRX -2.1% (still checking), LVS -2% (CEO Adelson says the Macau market is beginning to bottom out - Reuters ), ALIM -2% (discloses it promoted Richard Eiswirth to the position of President and Chief Financial Officer), NE -1.8% (still checking), UN -1.6% (still checking), RIG -1.5% (Statoil ASA decides to cancel the contract with Transocean for the drillship Discoverer Americas; announced that the SIX Swiss Exchange approved its application to delist its shares), FDX -1.4% (pulling back following yesterday's earnings related strength), AN -1.3% (KMX sympathy), MS -1.2% (WSJ reports that Morgan Stanley is planning to trim up to 5% of its stock-trading employees early next year), IRMD -1.1% (announces a proposed secondary offering of common stock, by CEO Roger Susi; size not disclosed),AZN -1.1% (updates on preliminary findings from the ATLANTIC trial of durvalumab as 3rd-line or later stage therapy in patients with NSCLC), INTC -0.9% (still checking), JBHT -0.8% (following KNX guidance), YHOO -0.7% (NYPost reports that some of Yahoo's (YHOO) activist shareholders are mulling a proxy battle), MRK -0.4% (Provides Update on European Medicines Agency Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir; anticipates a European Commission decision in mid-2016), KR -0.3% (Kroger completes tender offer for shares of Roundy's; initiated with a Outperform at Wells Fargo).
Analyst comments: FOSL -7.4% (downgraded to Sell from Neutral at Goldman), GLOP -2.3% (downgraded to Underweight from Neutral at JPMorgan), AIXG -1.2% (downgraded to Equal-Weight at Morgan Stanley), BA -1.1% (downgraded to Market Perform from Outperform at Wells Fargo), SGYP -0.7% (downgraded to Neutral from Buy at Citigroup), TXN -0.3% (downgraded to Mkt Perform from Outperform at Bernstein).